-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Zymeworks, Raises Price Target to $51

Benzinga·08/05/2026 17:49:20
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $46 to $51.